Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2005Antiviral TherapyOpen Access

Challenges for the Clinical Development of New Nucleoside Reverse Transcriptase Inhibitors for HIV Infection

View Full Paper
Ask AI
Bookmark
Share

Authors

MWMark A. WainbergJewish General HospitalJSJ. SawyerAstraZeneca (United Kingdom)JMJulio MontanerUniversità Cattolica del Sacro Cuore

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wainberg et al. (2005) studied this question.

synapsesocial.com/papers/6a89a191755d28965dfd4e32https://doi.org/10.1177/135965350501000119
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Once‐Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus–Infected Patients2000 · 116 citations
  2. 2Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom2001 · 157 citations
  3. 3Broad Nucleoside Reverse‐Transcriptase Inhibitor Cross‐Resistance in Human Immunodeficiency Virus Type 1 Clinical Isolates2003 · 216 citations
  4. 4Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance Therapy2000 · 371 citations